NL193267B - Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. - Google Patents
Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.Info
- Publication number
- NL193267B NL193267B NL9000428A NL9000428A NL193267B NL 193267 B NL193267 B NL 193267B NL 9000428 A NL9000428 A NL 9000428A NL 9000428 A NL9000428 A NL 9000428A NL 193267 B NL193267 B NL 193267B
- Authority
- NL
- Netherlands
- Prior art keywords
- pharmaceutical preparation
- gelatin capsule
- ranitidine hydrochloride
- filling containing
- containing ranitidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8904182 | 1989-02-23 | ||
GB898904182A GB8904182D0 (en) | 1989-02-23 | 1989-02-23 | Pharmaceutical compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
NL9000428A NL9000428A (nl) | 1990-09-17 |
NL193267B true NL193267B (nl) | 1999-01-04 |
NL193267C NL193267C (nl) | 1999-05-06 |
Family
ID=10652220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL9000428A NL193267C (nl) | 1989-02-23 | 1990-02-22 | Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. |
Country Status (26)
Country | Link |
---|---|
US (1) | US5028432A (nl) |
JP (1) | JP2856817B2 (nl) |
KR (1) | KR940006271B1 (nl) |
AT (1) | AT401727B (nl) |
AU (1) | AU629303B2 (nl) |
BE (1) | BE1003123A3 (nl) |
CA (1) | CA2010692C (nl) |
CH (1) | CH680567A5 (nl) |
CY (1) | CY1734A (nl) |
DE (1) | DE4005650C2 (nl) |
DK (1) | DK170209B1 (nl) |
FR (1) | FR2643263B1 (nl) |
GB (2) | GB8904182D0 (nl) |
HK (1) | HK89493A (nl) |
HU (1) | HU211930A9 (nl) |
IE (1) | IE63179B1 (nl) |
IL (1) | IL93490A (nl) |
IT (1) | IT1240768B (nl) |
LU (1) | LU87681A1 (nl) |
NL (1) | NL193267C (nl) |
NZ (1) | NZ232642A (nl) |
PH (1) | PH26972A (nl) |
SA (1) | SA90100287B1 (nl) |
SE (1) | SE512412C2 (nl) |
ZA (1) | ZA901348B (nl) |
ZW (1) | ZW1790A1 (nl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06501003A (ja) * | 1990-09-13 | 1994-01-27 | スミスクライン・ビーチャム・コーポレイション | 非水性液状経口懸濁液 |
US5571533A (en) * | 1992-02-07 | 1996-11-05 | Recordati, S.A., Chemical And Pharmaceutical Company | Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide |
WO1994008576A1 (en) * | 1992-10-16 | 1994-04-28 | Glaxo Group Limited | Taste-masking compositions of ranitidine |
US5433951A (en) * | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
DE4341310A1 (de) * | 1993-12-03 | 1995-06-08 | Hexal Pharma Gmbh | Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1 |
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
US5407687A (en) * | 1994-02-22 | 1995-04-18 | Glaxo Inc. | Ranitidine solid dosage form |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US5538737A (en) * | 1994-11-30 | 1996-07-23 | Applied Analytical Industries, Inc. | Oral compositions of H2 -antagonists |
GB9705813D0 (en) * | 1997-03-20 | 1997-05-07 | Smithkline Beecham Plc | Novel compositions |
AR013261A1 (es) * | 1997-08-01 | 2000-12-13 | Smithkline Beecham Corp | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina |
JP2005531495A (ja) * | 2001-12-21 | 2005-10-20 | シャイア ラボラトリーズ,インコーポレイテッド | 高い物理的安定性を有する経口カプセル製剤 |
EP1592760A4 (en) * | 2003-01-31 | 2009-08-12 | Smithkline Beecham Corp | AS FIXED DISPERSIONS, COMPOSITIONS |
PT1660047E (pt) | 2003-08-13 | 2014-02-27 | Biocon Ltd | Formulação de dosagem sólida de sais de ácidos gordos em micropartículas para agentes terapêuticos |
US9579269B2 (en) | 2010-06-23 | 2017-02-28 | Colgate-Palmolive Company | Therapeutic oral composition |
BR112013015574B1 (pt) | 2010-12-20 | 2018-02-06 | Colgate-Palmolive Company | Composição não aquosa para cuidado oral contendo ativos de oclusão dentária, método de limpeza dos dentes e escova de dentes |
CA2821371A1 (en) | 2010-12-20 | 2012-06-28 | Colgate-Palmolive Company | Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier |
JP2013545800A (ja) | 2010-12-20 | 2013-12-26 | コルゲート・パーモリブ・カンパニー | 親水性活性剤、疎水性構造化剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物 |
US20200038376A1 (en) * | 2016-11-01 | 2020-02-06 | Johnson & Johnson Consumer Inc. | Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid |
CN109010303B (zh) * | 2017-06-09 | 2021-05-07 | 苏州科伦药物研究有限公司 | 一种盐酸雷尼替丁胶囊的工业制备方法 |
KR102108153B1 (ko) * | 2017-07-05 | 2020-05-07 | (주)동구바이오제약 | 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3374146A (en) * | 1966-04-18 | 1968-03-19 | American Cyanamid Co | Sustained release encapsulation |
DE2360796B2 (de) * | 1973-12-06 | 1977-06-02 | Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München | Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm |
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
IT1090703B (it) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | Perfezionamento nelle composizioni utili quali veicolo per farmaci |
JPS5919524B2 (ja) * | 1976-12-17 | 1984-05-07 | 中外製薬株式会社 | 安定な1α−ヒドロキシビタミンD類含有製剤 |
GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
JPS55136219A (en) * | 1979-04-11 | 1980-10-23 | Sumitomo Chem Co Ltd | Diazepam oily drug |
EP0040489A1 (en) * | 1980-05-17 | 1981-11-25 | FISONS plc | Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine |
CY1306A (en) * | 1980-10-01 | 1985-12-06 | Glaxo Group Ltd | Aminoalkyl furan derivative |
IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
DE3264782D1 (en) * | 1981-10-16 | 1985-08-22 | Sanol Arznei Schwarz Gmbh | Medicinal formulation |
JPS58174308A (ja) * | 1982-04-06 | 1983-10-13 | Fujimoto Seiyaku Kk | レクタルカプセル坐剤 |
BE896711A (fr) * | 1982-05-14 | 1983-09-01 | Richter Gedeon Vegyeszet | Compositions pharmaceutiques anti-ulceres. |
DE3237814A1 (de) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Wasserfreie emulsionen und verwendung derselben |
KR890001179B1 (ko) * | 1983-08-01 | 1989-04-26 | 알.피.쉐레르 코오포레이션 | 지속적으로 방출되는 복용체 |
GB8903804D0 (en) * | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
GB8426738D0 (en) * | 1984-10-23 | 1984-11-28 | Scras | Pyridine derivatives |
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
JPH07549B2 (ja) * | 1986-07-03 | 1995-01-11 | ゼリア新薬工業株式会社 | 軟カプセル充填用組成物 |
DE3629386A1 (de) * | 1986-08-29 | 1988-03-03 | Scherer Gmbh R P | Gelatinekapseln und verfahren zu ihrer herstellung |
IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
FR2636532B1 (fr) * | 1988-09-20 | 1993-11-19 | Glaxo Group Ltd | Compositions pharmaceutiques |
-
1989
- 1989-02-23 GB GB898904182A patent/GB8904182D0/en active Pending
-
1990
- 1990-02-21 ZW ZW17/90A patent/ZW1790A1/xx unknown
- 1990-02-21 LU LU87681A patent/LU87681A1/fr unknown
- 1990-02-22 NL NL9000428A patent/NL193267C/nl not_active IP Right Cessation
- 1990-02-22 GB GB9004016A patent/GB2229094B/en not_active Expired - Lifetime
- 1990-02-22 CH CH569/90A patent/CH680567A5/fr not_active IP Right Cessation
- 1990-02-22 AT AT0042190A patent/AT401727B/de not_active IP Right Cessation
- 1990-02-22 BE BE9000197A patent/BE1003123A3/fr not_active IP Right Cessation
- 1990-02-22 KR KR1019900002250A patent/KR940006271B1/ko not_active IP Right Cessation
- 1990-02-22 IL IL9349090A patent/IL93490A/en not_active IP Right Cessation
- 1990-02-22 SE SE9000625A patent/SE512412C2/sv unknown
- 1990-02-22 NZ NZ232642A patent/NZ232642A/en unknown
- 1990-02-22 ZA ZA901348A patent/ZA901348B/xx unknown
- 1990-02-22 JP JP2042288A patent/JP2856817B2/ja not_active Expired - Lifetime
- 1990-02-22 FR FR909002187A patent/FR2643263B1/fr not_active Expired - Lifetime
- 1990-02-22 PH PH40086A patent/PH26972A/en unknown
- 1990-02-22 DE DE4005650A patent/DE4005650C2/de not_active Expired - Lifetime
- 1990-02-22 CA CA002010692A patent/CA2010692C/en not_active Expired - Lifetime
- 1990-02-22 AU AU50073/90A patent/AU629303B2/en not_active Expired
- 1990-02-22 DK DK048090A patent/DK170209B1/da not_active IP Right Cessation
- 1990-02-22 IT IT47659A patent/IT1240768B/it active IP Right Grant
- 1990-02-22 IE IE65190A patent/IE63179B1/en not_active IP Right Cessation
- 1990-02-22 US US07/482,903 patent/US5028432A/en not_active Expired - Lifetime
- 1990-06-23 SA SA90100287A patent/SA90100287B1/ar unknown
-
1993
- 1993-08-26 HK HK894/93A patent/HK89493A/xx not_active IP Right Cessation
-
1994
- 1994-05-06 CY CY173494A patent/CY1734A/xx unknown
-
1995
- 1995-06-29 HU HU95P/P00543P patent/HU211930A9/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL193267B (nl) | Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. | |
NL192604B (nl) | Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat. | |
NL194858B (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat in de vorm van microdeeltjes, en een werkwijze voor de bereiding van farmaceutisch preparaat in de vorm van een injecteerbare suspentie van microdeeltjes. | |
FR2636527B1 (fr) | Capsule pour medicaments | |
DE69011885D1 (de) | Auf die Mundschleimhaut aufbringbare Arzneizubereitung. | |
ATA905997A (de) | Pharmazeutische zubereitung, die ein mycophenolatsalz enthält | |
DE3863963D1 (de) | Pharmazeutische zusammensetzungen. | |
FR2633181B1 (fr) | Composition pharmaceutique a base de ranitidine et son procede de preparation | |
NL194239B (nl) | Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten. | |
NL192819B (nl) | Met een hydroxypropylmethylcellulosefilm beklede tablet van ranitidine hydrochloride. | |
DE3879111D1 (de) | Pharmazeutische kautablette mit geschmaksmaskierung. | |
NL194827B (nl) | Thieno-triazolo-diazepinederivaten en farmaceutische preparaten die een dergelijk derivaat bevatten. | |
NL194431B (nl) | Farmaceutische preparaten die ranitidine bevatten. | |
DK496889A (da) | Peptidholdigt farmaceutisk praeparat | |
NO892764D0 (no) | Medikamentell administreringsform for droevtyggere. | |
PT8357T (pt) | Embalagem para medicamentos com tampa de capuz | |
ES2021579B3 (es) | Capsulas divisibles en piezas | |
GB2228922B (en) | Packaging drugs | |
DE68915203D1 (de) | Pharmazeutische Mischungen. | |
DE58905160D1 (de) | Pharmazeutische zubereitung. | |
NL193441B (nl) | Farmaceutisch preparaat voor veterinair gebruik. | |
DE68902056D1 (de) | 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. | |
NL7812644A (nl) | N-koolwaterstofacylaminoalkaancarbonzuren, bereiding en toepassing daarvan, benevens geneesmiddelen, die deze verbindingen bevatten. | |
DE68912947D1 (de) | Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung. | |
FR2651436B1 (fr) | Compositions pharmaceutiques contenant un derive substitue soluble de dextrane. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Effective date: 20100222 |